[Current therapy concepts in chronic myeloid leukemia. Study IV of the German CML Study Group]

Internist (Berl). 2002 Oct;43(10):1228, 1231-8, 1241-4. doi: 10.1007/s00108-002-0706-6.

[Article in German]

Authors

A Hochhaus¹, U Berger, A Reiter, G Engelich, T Lahaye, S Kreil, K Merx, M C Müller, R Hehlmann

Affiliation

¹ III. Medizinische Universitätsklinik, Klinikum Mannheim, Universität Heidelberg, Wiesbadener Strasse 7-11, 68305 Mannheim. hochhaus@uni-hd.de

PMID: 12524904
DOI: 10.1007/s00108-002-0706-6

No abstract available

Publication types

Comparative Study
Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Benzamides
Chromosome Aberrations
Fusion Proteins, bcr-abl / genetics
Humans
Hydroxyurea / administration & dosage
Imatinib Mesylate
Interferon-alpha / administration & dosage
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / classification
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
Piperazines / administration & dosage
Protein-Tyrosine Kinases / antagonists & inhibitors
Pyrimidines / administration & dosage
Randomized Controlled Trials as Topic
Stem Cell Transplantation

Substances

Benzamides
Interferon-alpha
Piperazines
Pyrimidines
Imatinib Mesylate
Protein-Tyrosine Kinases
Fusion Proteins, bcr-abl
Hydroxyurea